info@seagull-health.com
SeagullHealth
语言:
search
new
What are the suitable populations for Sparsentan(Filspari)?
500
Article source: Seagull Pharmacy
Jun 20, 2025

Sparsentan(Filspari) is a white or off-white oval film-coated tablet, is a unique single-molecule drug, used in clinical treatment of primary immunoglobulin A nephropathy (IgAN), has the title of "orphan drug" for the treatment of IgA nephropathy, in order to let everyone know more about Sparsentan, the following will be a detailed introduction to the adapted population of Sparsentan.

What are the suitable populations for Sparsentan(Filspari)?

Sparsentan(Filspari) is mainly indicated for adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease progression and have a urine protein-to-creatinine ratio (UPCR) of ≥1.5g/g, including pregnant women and patients taking renin-angiotensin-aldosterone system (RAAS) inhibitors, endothelin receptor antagonists (ERAs), or aliskiren.

Sparsentan has not yet been marketed in China, patients and their families can not directly purchase through the domestic market, if necessary, they can consult and purchase through the overseas medical consulting service platform, pay attention to choose a reliable platform, pay attention to the identification of counterfeit and shoddy drugs, the drug needs to be carried out under the guidance of the doctor, if there are any adverse reactions in the process of medication, the doctor should be responded to in time, so as to make timely adjustment of the medication plan and symptomatic treatment.

Daily care of patients with primary immunoglobulin A nephropathy (IgAN)

The day-to-day care of patients with primary immunoglobulin A nephropathy (IgAN) requires a combination of diet, monitoring, and lifestyle. Only by satisfying comprehensive and meticulous care can the progression of the disease be effectively controlled and the quality of life of patients improved.

Dietary modifications

Patients with IgAN should follow a low-salt, low-fat, high-protein diet. Avoid consuming too much salt to reduce the burden on your kidneys. Choose high-quality protein sources such as lean meat, eggs, and milk to meet your body's needs. Increase the intake of vegetables and fruits to maintain a balanced nutrition.

Regular monitoring

Patients should be regularly monitored for renal function, urinalysis, blood pressure and other indicators to keep abreast of the progress of the disease. Pay attention to the changes in the color and amount of urine, and seek medical attention in time if there is any abnormality.

Lifestyle modifications

Maintain a regular routine and avoid staying up late and overexertion. Appropriate physical exercises, such as walking, jogging, etc., to strengthen the body's resistance. Pay attention to personal hygiene to prevent infection. Avoid the use of nephrotoxic drugs to reduce the burden on the kidneys.

When purchasing medicines, it is important to ensure that the purchase channel is regular. It is recommended to choose a reputable and regular pharmacy or medical institution to purchase to ensure the quality of the medicine. Avoid buying medicines from unknown sources to avoid encountering counterfeit and shoddy products that can harm your health. Choose formal channels carefully.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Sparsentan(Filspari)
Sparsentan(Filspari)
Adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk...
WeChat Scan
Free Inquiry
Recommended Articles
What kinds of diseases is Sparsentan(Filspari) suitable for?
The main ingredient of Filspari is Sparsentan, which acts on ETAR and AT1R, can reduce the level of proteinuria in patients, and has the "orphan drug title" for the treatment of IgA nep...
Indications for Sparsentan
Sparsentan, also known as Filspari, is an innovative drug with specific therapeutic effects. This article will elaborate on the indications, drug interactions and basic pharmacological effects of Spar...
Things to note when using tazemetostat
Tazemetostat is a new generation of oral tyrosine kinase inhibitors, designed specifically for a variety of hematologic and solid-related diseases. By accurately blocking abnormal cell signaling ...
How to use Tazemetostat and its precautions
Tazemetostat is an innovative targeted therapeutic drug, mainly used to treat specific types of related diseases. By accurately inhibiting the key signaling pathways in the growth of cells in rel...
Guidelines for the use of Sparsentan
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will explore how the drug is used, how well i...
How to use Sparsentan?
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will introduce in detail how to use this drug...
Guidelines for the use of Sparsentan
Sparsentan is a drug used to treat primary immunoglobulin A nephropathy (IgAN) with a risk of rapid disease progression, improving the condition by lowering the patient's proteinuria levels. This ...
Filspari/Sparsentan has a good effect on the treatment of lgA nephropathy
Sparsentan, also known as Filspari, is a drug used to treat primary immunoglobulin A nephropathy (IgA nephropathy). It significantly reduces proteinuria levels and delays disease progression by dual i...
Related Articles
Dosage and Administration of Sparsentan (Filspari)
Sparsentan (Filspari) is a dual antagonist of endothelin and angiotensin II receptors, which was first approved in the United States in 2023. This medication is mainly used to slow the decline of rena...
What are the Indications of Sparsentan (Filspari)?
Sparsentan (Filspari) is a new type of oral medication, which was first approved for marketing in the United States in 2023. It is a dual endothelin and angiotensin II receptor antagonist, suitable fo...
What Are the Purchase Channels for Sparsentan (Filspari)?
Sparsentan (Filspari) is a novel dual endothelin and angiotensin II receptor antagonist, which holds significant clinical value in delaying the decline of renal function in adult patients with primary...
Things to note about Sparsentan
Sparsentan is clinically suitable for adult patients with primary immunoglobulin A nephropathy (IgAN). It has the title of "orphan drug" for the treatment of IgA nephropathy. Many patie...
What should I pay attention to when taking Filspari?
Filspari is clinically suitable for adult patients with primary immunoglobulin A nephropathy (IgAN). It has the title of "orphan drug" for the treatment of IgA nephropathy. Many patient...
Side effects of Sparsentan
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will provide detailed descriptions of po...
How to relieve side effects of Sparsentan?
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will provide detailed descriptions on ho...
Sparsentan side effects and precautions
Sparsentan is a drug used to treat primary immunoglobulin A nephropathy (IgAN) by targeting ETAR and AT1R receptors to reduce proteinuria levels.Sparsentan side effects and precautionsSparse...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved